EUVIMEDEUVIMED entdecken
Crossref

Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging

Di Hua, Hongjie Xi, Quan Xie, Shuyue Cai, Yuxuan Zhou, Xin Hu, Ling Qiu, Jianguo Lin

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.149646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Di Hua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China; NHC Key Laboratory of Nuclear Medicine, J…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Neoplasms, Cysteine Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Legumain is overexpressed in diverse tumors, serving as a significant tumor biomarker. Our study aimed to develop a new positron emission tomography (PET) probe [68Ga]Ga-NOTA-SF-AANM for imaging the expression level of legumain in vivo. The radio-labeling of [68Ga]Ga-NOTA-SF-AANM was accomplished within 15 min. The probe has good stability in vitro. NOTA-SF-AANM exhibited rapid response to recombinant human legumain enzyme, enabling intramolecular condensation cyclization. Cellular uptake and lysosomal co-localization experiments demonstrated that the probe was able to differentiate specifically between MDA-MB-468 and PC-3 cancer cells with varying degrees of legumain expression. PET imaging displayed a significant and persistent signal (3.59 ± 0.30 %ID/mL at 60 min) in MDA-MB-468 tumors, while PC-3 tumors exhibited lower radioactivity (1.08 ± 0.35 %ID/mL at 60 min), further validating the specific targeting of [68Ga]Ga-NOTA-SF-AANM towards legumain. [68Ga]Ga-NOTA-SF-AANM is a promising tool for precise diagnosis of legumain-related diseases due to its advantages in radio-labeling and accurate monitoring of legumain expression levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesNeoplasmsCysteine EndopeptidasesHumansPositron-Emission TomographyLysosomesCell Line, TumorAsparaginyl Endopeptidase

Stichwörter der Autor:innen

(68)Ga-labelingCancerLegumainLysosomePositron emission tomography

Substanzen

Gallium RadioisotopesCysteine EndopeptidasesAsparaginyl Endopeptidase

Autor:innen und Institutionen

  • Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China; NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hua, D., Xi, H., Xie, Q., Cai, S., Zhou, Y., Hu, X., Qiu, L., & Lin, J. (2024). Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.149646

Vancouver

Hua D, Xi H, Xie Q, Cai S, Zhou Y, Hu X, et al. Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.149646

BibTeX
@article{Hua2024,
  author = {Hua, Di and Xi, Hongjie and Xie, Quan and Cai, Shuyue and Zhou, Yuxuan and Hu, Xin and Qiu, Ling and Lin, Jianguo},
  title = {Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.149646}
}
Kostenlos starten →